LIVE MARKETS-Cheaper GLP-1 drugs could put packaged foods on a crash diet, says Piper Sandler

Reuters
11/24
LIVE MARKETS-Cheaper GLP-1 drugs could put packaged foods on a crash diet, says Piper Sandler

STOXX 600 steady

Defence stocks lag

U.S. futures higher

Adds blog post

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.

CHEAPER GLP-1 DRUGS COULD PUT PACKAGED FOODS ON A CRASH DIET SAYS PIPER SANDLER

When weight-loss drugs start slimming down grocery aisles, it's not just waistlines that feel the pinch, packaged food makers are also under pressure, Piper Sandler said.

The brokerage estimates in a recent note, that roughly 20% or one in five of the U.S. population could be GLP-1 users by 2028, a surge driven by oral versions of Eli Lilly's LLY.N orforglipron and Novo Nordisk's NOVOb.CO Wegovy.

That uptake could translate into a 45–110 basis point annual hit to packaged food sales, with cumulative headwinds reaching 325 bps by 2028.

That marks a sharp shift from Piper's October view, when they described GLP-1s as a "modest and manageable" risk and forecast only a 20–30 bps annual drag as high costs kept adoption limited. Inflation was seen as the bigger diet driver then, with food prices up 25–30% since 2020 and volumes under pressure.

Cheaper GLP-1 treatments, enabled by Medicare and Medicaid coverage and TrumpRX, a direct-to-consumer discount program—starting in 2026, are partly behind their change of stance.

The price cuts follow deals struck by President Trump with Eli Lilly and Novo Nordisk to lower costs for obesity and diabetes drugs.

The brokerage says the pain won't be evenly distributed. Alcoholic beverages and high-sugar, high-carb foods are in the crosshairs, as GLP-1 users tend to cut back on indulgences and booze while favouring healthier options.

Piper said in a note on Friday that it expects beer makers like Molson Coors TAP.N and Boston Beer SAM.N to face incremental declines on top of already weak category trends, while snack giants such as Hershey HSY.N and Kellogg could see sharper spending cuts.

Piper says Celsius CELH.O , Coca-Cola KO.N, Keurig Dr PepperKDP.O , MonsterMNST.O , and Vita Coco COCO.O are best positioned, buoyed by modest gains in non-alcoholic beverages—especially sugar-free alternatives. Freshpet FRPT.O also looks insulated from GLP-1 headwinds.

(Rashika Singh)

EARLIER LIVE MARKETS POSTS:

EYES ON PEACE TALKS CLICK HERE

EUROPE BEFORE THE BELL: CATCH UP AND THEN WHAT? CLICK HERE

MORNING BID: HOLIDAY WEEK COULD BE PRIME TIME FOR YEN INTERVENTION CLICK HERE

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10